From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia
Innovation Discovery · 2024
DOI: 10.53964/id.2024007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Innovation Discovery, 2024. Verfasst von Ghazi Elamin und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref).
Abstract (Originalsprache)
From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia
Zitieren
APA
Elamin, G., Aljoundi, A., & Soliman, M. E. (2024). From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia. Innovation Discovery. https://doi.org/10.53964/id.2024007
Vancouver
Elamin G, Aljoundi A, Soliman ME. From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia. Innovation Discovery. 2024. doi:10.53964/id.2024007
BibTeX
@article{Elamin2024,
author = {Elamin, Ghazi and Aljoundi, Aimen and Soliman, Mahmoud E.S.},
title = {From Biological Activity to Stereoselectivity: A Portrait of Molecular and Mechanistic Profiles of the Therapeutic Potential of G-1 and LNS8801 as GPER-1 Activator in the Treatment of Waldenström’s Macroglobulinemia},
journal = {Innovation Discovery},
year = {2024},
doi = {10.53964/id.2024007}
}
EUVIMED